Psy Therapeutics, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Psy Therapeutics, Inc.
Quantité totale PI 14
Rang # Quantité totale PI 110 722
Note d'activité PI 2,2/5.0    18
Rang # Activité PI 46 042
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

5 2
1 0
6 0
0
 
Dernier brevet 2025 - Inhibiting monoacylglycerol lipa...
Premier brevet 2022 - Inhibiting monoacylglycerol lipa...
Dernière marque 2022 - PSY THERAPEUTICS
Première marque 2019 - PSY THERAPEUTICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Inhibiting monoacylglycerol lipase (magl). Provided herein are compounds for inhibiting monoacyl...
2024 Invention Monoacylglycerol lipase inhibitors and use thereof for the treatment of neurological disorders. P...
Invention Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of inflammato...
Invention Inhibiting monoacylglycerol lipase (magl). Provided herein are compounds for inhibiting monoacylg...
2022 Invention Monoacylglycerol lipase inhibitors and use thereof for the treatment of anxiety and related condi...
Invention Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of pain and r...
Invention Inhibiting monoacylglycerol lipase (magl). Provided herein are 1H-pyrazol-5-yl)-2-azaspiro[3.3]h...
Invention Inhibiting monoacylglycerol lipase (magl). Provided herein are 1 H-pyrazol-5-yl)-2-azaspiro[3.3]h...
Invention Monoacylglycerol lipase inhibitors and use thereof for the treatment of anxiety. Provided herein ...
Invention Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of pain. Prov...
P/S Pharmaceuticals preparations and therapeutic pharmaceuticals for the treatment of central nervous...
2019 P/S Pharmaceutical research and development; scientific research and development; medical research